Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |